berotralstat hydrochloride
Marketedupdated 2mo agoby $BCRX BIOCRYST PHARMACEUTICALS INC
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for 4 indications.
all catalysts(5)
approval · 5
Dec 3, 2020
approval
ORLADEYO (BEROTRALSTAT DIHYDROCHLORIDE) — FDA approval
berotralstat hydrochloride
→
Nov 21, 2023
approval
ORLADEYO (BEROTRALSTAT DIHYDROCHLORIDE) — FDA approval
berotralstat hydrochloride
→
Oct 21, 2024
approval
ORLADEYO (BEROTRALSTAT DIHYDROCHLORIDE) — FDA approval
berotralstat hydrochloride
→
Dec 11, 2025
approval
ORLADEYO (BEROTRALSTAT DIHYDROCHLORIDE) — FDA approval
berotralstat hydrochloride
→
Dec 23, 2025
approval
ORLADEYO (BEROTRALSTAT DIHYDROCHLORIDE) — FDA approval
berotralstat hydrochloride
→
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that